Sentien biotechnologies, INC.: r & d of EX vivo cell therapy
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00072
- Awardee
-
Sentien Biotechnologies, Inc. UEI NDAYRDKCMBJ7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $510,265
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $510,265.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 30 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Lexington, MA 02421, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$239,734 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $63,377 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $686,622 |
About this award
Sentien Biotechnologies, Inc. was awarded a $510,265 definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to conduct research and development of ex vivo cell therapy. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury. Sentien Biotechnologies will pursue safety review of candidates through Phase I and share data and commercialization plans under the firm fixed price contract ending February 28, 2023. No subcontractors or set aside designations were indicated.
Quick answers
Who was awarded contract 75A50121C00072?
75A50121C00072 was awarded to Sentien Biotechnologies, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 18, 2021.
How much is contract 75A50121C00072 worth?
The government has obligated $510,265 on 75A50121C00072.
Was contract 75A50121C00072 competed?
The extent of competition for 75A50121C00072 was full and open competition. The government received 30 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award